Recruiting |
: S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia
: - Acute Leukemias of Ambiguous Lineage
- B-cell Adult Acute Lymphob
: 2013-08-15
: - Drug: cyclophosphamide Given I
|
Recruiting |
: Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
: - B Acute Lymphoblastic Leukemia
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR
: 2016-08-23
: - Biological: Blinatumomab Given
|
Completed |
: Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
: - Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
-
- Drug: Selinexor Given orally o
|
Recruiting |
: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
: - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Acut
: 2014-08-18
: - Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
|
Active, not recruiting |
: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
: - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Acut
: 2013-05-15
: - Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
|
Recruiting |
: Decitabine, Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
: - de Novo Myelodysplastic Syndrome
- Mixed Phenotype Acute Leukemia
: 2016-09-29
: - Drug: Cladribine Given IV
|
Active, not recruiting |
: POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients
: - Relapsed/Refractory AML
- Relapsed/Refractory ALL
- Secondary
: 2011-03-11
: Drug: Plerixafor Dose Escalation Plerixafor dose escalatio
|
Recruiting |
: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
: - Acute Biphenotypic Leukemia
- Acute Erythroid Leukemia
: 2012-09-19
: - Drug: Cyclophosphamide Given I
|
Recruiting |
: High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
: - Acute Leukemia of Ambiguous Lineage
- Recurrent Adult Acute Lymph
: 2015-08-25
: - Other: Chemosensitivity Assay
|
Active, not recruiting |
: Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
: - Acute Leukemias of Ambiguous Lineage
- Bacterial Infection
<
: 2011-06-04
: Drug: levofloxacin Given PO or IV Other Names:
|